These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11888529)

  • 61. Haptoglobin polymorphism and mortality in patients with tuberculosis.
    Kasvosve I; Gomo ZA; Mvundura E; Moyo VM; Saungweme T; Khumalo H; Gordeuk VR; Boelaert JR; Delanghe JR; De Bacquer D; Gangaidzo IT
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):771-5. PubMed ID: 10949330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coronary artery disease in diabetic and nondiabetic patients: a clinical and angiographic comparison.
    Wilson CS; Gau GT; Fulton RE; Davis GD
    Clin Cardiol; 1983 Sep; 6(9):440-6. PubMed ID: 6627773
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers.
    Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N
    Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Haptoglobin polymorphism and peripheral arterial occlusive disease.
    Delanghe J; Langlois M; Duprez D; De Buyzere M; Clement D
    Atherosclerosis; 1999 Aug; 145(2):287-92. PubMed ID: 10488955
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus.
    Werner GS; Richartz BM; Heinke S; Ferrari M; Figulla HR
    Eur Heart J; 2003 Jun; 24(12):1134-42. PubMed ID: 12804928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Haptoglobin groups and cirrhosis of the liver.
    Zhao H; Zhang G
    Hum Hered; 1993; 43(2):134-6. PubMed ID: 8395462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A study of haptoglobin phenotypes in patients with chronic renal failure.
    Awadallah S; Hamad M
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):680-3. PubMed ID: 14629808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of the haptoglobin phenotype on the size of a myocardial infarct.
    Chapelle JP; Albert A; Smeets JP; Heusghem C; Kulbertus HE
    N Engl J Med; 1982 Aug; 307(8):457-63. PubMed ID: 7099207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
    Vitalis Z; Altorjay I; Tornai I; Palatka K; Kacska S; Palyu E; Tornai D; Udvardy M; Harsfalvi J; Dinya T; Veres G; Lakatos PL; Papp M
    Hum Immunol; 2011 Apr; 72(4):348-54. PubMed ID: 21262313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease.
    Seiler C; Fleisch M; Billinger M; Meier B
    J Am Coll Cardiol; 1999 Dec; 34(7):1985-94. PubMed ID: 10588214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality.
    De Bacquer D; De Backer G; Langlois M; Delanghe J; Kesteloot H; Kornitzer M
    Atherosclerosis; 2001 Jul; 157(1):161-6. PubMed ID: 11427216
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
    Laakso M; Kesäniemi A; Kervinen K; Jauhiainen M; Pyörälä K
    BMJ; 1991 Nov; 303(6811):1159-62. PubMed ID: 1747611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion.
    Hansen JF
    Am Heart J; 1989 Feb; 117(2):290-5. PubMed ID: 2916404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?
    Frand J; Borislavsky A; Boaz M; Matas Z; Shargorodsky M
    Atherosclerosis; 2013 Jan; 226(1):146-8. PubMed ID: 23177015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease.
    Arslan U; Kocaoğlu I; Balcı M; Duyuler S; Korkmaz A
    J Cardiol; 2012 Sep; 60(3):210-4. PubMed ID: 22738690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography.
    Sabia PJ; Powers ER; Jayaweera AR; Ragosta M; Kaul S
    Circulation; 1992 Jun; 85(6):2080-9. PubMed ID: 1591827
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.
    Dincer I; Ongun A; Turhan S; Ozdol C; Ertas F; Erol C
    Am J Cardiol; 2006 Mar; 97(6):772-4. PubMed ID: 16516573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of genetic markers with coronary heart disease (myocardial infarction)--a case-control study.
    Golabi P; Kshatriya GK; Kapoor AK
    J Indian Med Assoc; 1999 Jan; 97(1):6-7. PubMed ID: 10549177
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Collateral flow prevents unintentional myocardial ischemia during antegrade cardioplegia in patients undergoing coronary artery bypass grafting.
    Caretta Q; Voci P; Acconcia MC; Chiarotti F
    J Thorac Cardiovasc Surg; 1997 Mar; 113(3):585-93. PubMed ID: 9081106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.